INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION

This adverse event was reported 539 times

These drugs are most commonly taken by patients reporting INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION:

# Drug Count
0 BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE 137
1 BUPRENORPHINE 40
2 DUPILUMAB 30
3 GABAPENTIN 24
4 BUDESONIDE 23
5 CLOZAPINE 23
6 ACETAMINOPHEN 22
7 ASPIRIN 17
8 ASPIRIN 325 MG 17
9 ASPIRIN 81 MG 17
See all common drugs associated with INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION

INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE 137 0.0056
1 ODEVIXIBAT 1 0.0025
2 BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE 4 0.0017
3 TESTOSTERONE ENANTHATE 2 0.0012
4 RILONACEPT 1 0.0009
5 BUPRENORPHINE AND NALOXONE 1 0.0008
6 MITAPIVAT 1 0.0008
7 STANDARDIZED SENNA CONCENTRATE 9 0.0007
8 METHYLNALTREXONE BROMIDE 1 0.0007
9 PHENTERMINE AND TOPIRAMATE 4 0.0006
See all drugs enriched for association with INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION